Health Law Events

In a recent speech, a senior official at the U.S. Department of Justice Antitrust Division noted that “in U.S. antitrust enforcement and competition policy, there is no more important question than what can we do to safeguard competition in the health care industry.” Consistent with this sentiment, 2023 has witnessed an increase in investigations and enforcement […]

After the enactment of the Inflation Reduction Act, which enables Medicare to negotiate the price of certain prescription drugs, Congress is again attempting to lower the cost of prescription drugs. This time—in a rare bipartisan effort—Congress is focusing on pharmacy benefit managers (PBMs). PBMs are third-party “middlemen” contracted by insurance plans to manage prescription drug […]

Many commentators have sounded the alarm about bias in artificial intelligence and other digital technology. But what if such technology could instead be a powerful tool to advance diversity, equity, and inclusion? In her book The Equality Machine, legal and tech scholar Orly Lobel argues that digital technology holds tremendous promise—it can detect discrimination, close pay […]

In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold. In the United States, many types of psychedelics are being investigated for use in treating an array of mental health conditions. The U.S. nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) has announced promising phase 3 clinical trial results for […]

COVID-19 greatly accelerated the adoption of telehealth, and now three years later, states are exploring new policies to expand or streamline the state licensure process for physicians while ensuring continued authority to regulate and oversee the practice of medicine. In a new webinar, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH will moderate a panel […]

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide mental health benefits, including coverage for substance use disorders (SUDs), that are in “parity” with medical and surgical benefits. The exploding opioid and SUD crisis coupled with the soaring rates of mental health conditions post-COVID have put mental health parity in […]

From the end of the COVID-19 public health emergency (PHE) to the overturning of Roe v. Wade to the skyrocketing growth of virtual care, multiple forces are converging to remap the health care landscape. In a new webinar, Manatt Health will draw on the deep-dive legal, policy and market analyses in its Manatt on Health premium information service to […]

Over the past few years, there has been tightening enforcement and numerous lawsuits driven by the increasingly complex web of federal and state anti-kickback and anti-inducement statutes. In a new CLE-eligible webinar, Manatt Health will guide plans and providers through the emerging landscape of fraudulent health care schemes—and provide practical answers to the legal questions […]

The inclusion of racial and ethnic groups in clinical trials has been a national priority for decades, but progress toward that goal has been limited. When the COVID-19 pandemic threw into stark relief the underlying inequities in health care access (and therefore in clinical trial access), Congress and the Administration were moved to action. In […]

Individuals leaving incarceration have disproportionately higher rates of physical and behavioral health diagnoses and are at higher risk for injury and death compared with people who have not been incarcerated. Race disparities in incarceration further exacerbate health inequities for people of color upon release. Justice-involved individuals often will be released into the community with no […]